{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:57:56Z","timestamp":1790881076806,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973736"],"award-info":[{"award-number":["81973736"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017577","name":"Zhejiang Province Basic Public Welfare Research Program","doi-asserted-by":"publisher","award":["LY23H270008"],"award-info":[{"award-number":["LY23H270008"]}],"id":[{"id":"10.13039\/501100017577","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.phymed.2024.155916","type":"journal-article","created":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T16:02:21Z","timestamp":1722096141000},"page":"155916","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Jiawei Taohe Chengqi Decoction attenuates CCl4 induced hepatic fibrosis by inhibiting HSCs activation via TGF-\u03b21\/CUGBP1 and IFN-\u03b3\/Smad7 pathway"],"prefix":"10.1016","volume":"133","author":[{"given":"Linmao","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiguang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5211-7484","authenticated-orcid":false,"given":"Junjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.phymed.2024.155916_bib0001","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/s41590-019-0466-2","article-title":"Interferon target-gene expression and epigenomic signatures in health and disease","volume":"20","author":"Barrat","year":"2019","journal-title":"Nat. Immunol."},{"issue":"570","key":"10.1016\/j.phymed.2024.155916_bib0002","doi-asserted-by":"crossref","first-page":"eaav5183","DOI":"10.1126\/scisignal.aav5183","article-title":"Specificity, versatility, and control of TGF-\u03b2 family signaling","volume":"12","author":"Derynck","year":"2019","journal-title":"Sci. Signal"},{"issue":"11","key":"10.1016\/j.phymed.2024.155916_bib0003","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.3390\/cells8111419","article-title":"TGF-\u03b2 in hepatic stellate cell activation and liver fibrogenesis-updated 2019","volume":"8","author":"Dewidar","year":"2019","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.phymed.2024.155916_bib0004","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/hep4.1619","article-title":"Efficacy and safety of cenicriviroc in patients with primary sclerosing cholangitis: PERSEUS study","volume":"5","author":"Eksteen","year":"2020","journal-title":"Hepatol. Commun."},{"issue":"1","key":"10.1016\/j.phymed.2024.155916_bib0005","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/jcp.30915","article-title":"Intercellular communication among liver cells in the perisinusoidal space of the injured liver: pathophysiology and therapeutic directions","volume":"238","author":"Ezhilarasan","year":"2023","journal-title":"J. Cell. Physiol."},{"issue":"2","key":"10.1016\/j.phymed.2024.155916_bib0006","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/hep.32285","article-title":"Hepatic fibrosis 2022: unmet needs and a blueprint for the future","volume":"75","author":"Friedman","year":"2022","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.phymed.2024.155916_bib0007","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jhep.2018.10.008","article-title":"Hepatocellular carcinoma in the setting of alcohol-related liver disease","volume":"70","author":"Ganne-Carri\u00e9","year":"2019","journal-title":"J. Hepatol."},{"issue":"12","key":"10.1016\/j.phymed.2024.155916_bib0008","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.12998\/wjcc.v10.i12.3662","article-title":"Pathophysiological mechanisms of hepatic stellate cells activation in liver fibrosis","volume":"10","author":"Garbuzenko","year":"2022","journal-title":"World J. Clin. Cases"},{"key":"10.1016\/j.phymed.2024.155916_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117909","article-title":"Activation of Nrf2\/AREs-mediated antioxidant signalling, and suppression of profibrotic TGF-\u03b21\/Smad3 pathway: a promising therapeutic strategy for hepatic fibrosis - A review","volume":"256","author":"Gong","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.phymed.2024.155916_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154587","article-title":"Glycyrrhizic acid alleviates liver fibrosis in vitro and in vivo via activating CUGBP1-mediated IFN-\u03b3\/STAT1\/Smad7 pathway","volume":"112","author":"Guo","year":"2023","journal-title":"Phytomedicine"},{"issue":"10","key":"10.1016\/j.phymed.2024.155916_bib0011","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41575-023-00807-x","article-title":"Hepatic inflammatory responses in liver fibrosis","volume":"20","author":"Hammerich","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.phymed.2024.155916_bib0012","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1328094","article-title":"Immunoregulatory functions and therapeutic potential of natural killer cell-derived extracellular vesicles in chronic diseases","volume":"14","author":"He","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phymed.2024.155916_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.116059","article-title":"Jiawei Taohe Chengqi decoction attenuates hepatic fibrosis by preventing activation of HSCs through regulating Src\/ERK\/Smad3 signal pathway","volume":"305","author":"Huang","year":"2023","journal-title":"J. Ethnopharmacol."},{"issue":"9","key":"10.1016\/j.phymed.2024.155916_bib0014","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.3390\/cells11091500","article-title":"Recent advancements in antifibrotic therapies for regression of liver fibrosis","volume":"11","author":"Jangra","year":"2022","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.phymed.2024.155916_bib0015","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.arr.2012.02.007","article-title":"The role of CUGBP1 in age-dependent changes of liver functions","volume":"11","author":"Jones","year":"2012","journal-title":"Ageing Res. Rev."},{"issue":"11","key":"10.1016\/j.phymed.2024.155916_bib0016","doi-asserted-by":"crossref","first-page":"12435","DOI":"10.1096\/fj.201901046R","article-title":"Therapeutic effects of a small molecule agonist of the relaxin receptor ML290 in liver fibrosis","volume":"33","author":"Kaftanovskaya","year":"2019","journal-title":"FASEB J."},{"issue":"8","key":"10.1016\/j.phymed.2024.155916_bib0017","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1113\/JP281061","article-title":"Hepatic stellate cells in physiology and pathology","volume":"600","author":"Kamm","year":"2022","journal-title":"J. Physiol. (Lond.)"},{"issue":"1","key":"10.1016\/j.phymed.2024.155916_bib0018","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.canlet.2006.12.016","article-title":"TGF-beta-induced transcriptional activation of MMP-2 is mediated by activating transcription factor (ATF)2 in human breast epithelial cells","volume":"252","author":"Kim","year":"2007","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phymed.2024.155916_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113869","article-title":"Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis","volume":"176","author":"Kumar","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"16","key":"10.1016\/j.phymed.2024.155916_bib0020","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00128-17","article-title":"RNA binding protein CUGBP1 inhibits liver cancer in a phosphorylation-dependent manner","volume":"37","author":"Lewis","year":"2017","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.phymed.2024.155916_bib0021","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.phrs.2019.04.025","article-title":"Natural products in licorice for the therapy of liver diseases: progress and future opportunities","volume":"144","author":"Li","year":"2019","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.phymed.2024.155916_bib0022","first-page":"E10","article-title":"Suppression of CUGBP1 inhibits growth of hepatocellular carcinoma cells. Clinical and investigative medicine","volume":"37","author":"Liu","year":"2014","journal-title":"Med. Clin. Exp."},{"issue":"2","key":"10.1016\/j.phymed.2024.155916_bib0023","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41419-022-04570-w","article-title":"CUGBP1, a crucial factor for heart regeneration in mice","volume":"13","author":"Liu","year":"2022","journal-title":"Cell Death Dis."},{"issue":"10","key":"10.1016\/j.phymed.2024.155916_bib0024","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1089\/jmf.2010.1485","article-title":"Ginsenoside Rb1 inhibits cell activation and liver fibrosis in rat hepatic stellate cells","volume":"14","author":"Lo","year":"2011","journal-title":"J. Med. Food"},{"key":"10.1016\/j.phymed.2024.155916_bib0025","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5325431","article-title":"Pathogenesis of liver fibrosis and its TCM therapeutic perspectives","volume":"2022","author":"Nan","year":"2022","journal-title":"Evid. Based Complement Alternat. Med."},{"issue":"11","key":"10.1016\/j.phymed.2024.155916_bib0026","doi-asserted-by":"crossref","first-page":"9671","DOI":"10.3390\/ijms24119671","article-title":"Liver fibrosis resolution: from molecular mechanisms to therapeutic opportunities","volume":"24","author":"Pei","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.phymed.2024.155916_bib0027","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1053\/j.gastro.2008.03.078","article-title":"Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial","volume":"135","author":"Ratziu","year":"2008","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.phymed.2024.155916_bib0028","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/hep.31108","article-title":"Cenicriviroc treatment for adults with nonalcoholic steatohepatitis and fibrosis: final analysis of the phase 2b CENTAUR study","volume":"72","author":"Ratziu","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.phymed.2024.155916_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.110289","article-title":"Transforming growth factor-\u03b2 signaling: from tissue fibrosis to therapeutic opportunities","volume":"369","author":"Ren","year":"2023","journal-title":"Chem. Biol. Interact."},{"issue":"4","key":"10.1016\/j.phymed.2024.155916_bib0030","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3390\/cells9040875","article-title":"Liver fibrosis: mechanistic concepts and therapeutic perspectives","volume":"9","author":"Roehlen","year":"2020","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.phymed.2024.155916_bib0031","doi-asserted-by":"crossref","first-page":"422","DOI":"10.4314\/ahs.v23i2.49","article-title":"Alisma Shugan Decoction attenuates hepatic fibrosis and endoplasmic reticulum stress in mice with carbon tetrachloride-induced fibrosis","volume":"23","author":"Sun","year":"2023","journal-title":"Afr. Health Sci."},{"issue":"11","key":"10.1016\/j.phymed.2024.155916_bib0032","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1016\/j.cgh.2020.03.001","article-title":"Persistent low level of hepatitis B virus promotes fibrosis progression during therapy","volume":"18","author":"Sun","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"5","key":"10.1016\/j.phymed.2024.155916_bib0033","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1093\/nar\/gkac139","article-title":"Small molecule targeting CELF1 RNA-binding activity to control HSC activation and liver fibrosis","volume":"50","author":"Tan","year":"2022","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.phymed.2024.155916_bib0034","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1053\/j.gastro.2023.01.033","article-title":"Global epidemiology and genetics of hepatocellular carcinoma","volume":"164","author":"Toh","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.phymed.2024.155916_bib0035","article-title":"Molecular mechanisms and potential new therapeutic drugs for liver fibrosis","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phymed.2024.155916_bib0036","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.2147\/DDDT.S194787","article-title":"Salvianolic acid A attenuates CCl4-induced liver fibrosis by regulating the PI3K\/AKT\/mTOR, Bcl-2\/Bax and caspase-3\/cleaved caspase-3 signaling pathways","volume":"13","author":"Wang","year":"2019","journal-title":"Drug Des. Devel Ther."},{"issue":"2","key":"10.1016\/j.phymed.2024.155916_bib0037","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jhep.2019.03.012","article-title":"KLRG1+ natural killer cells exert a novel antifibrotic function in chronic hepatitis B","volume":"71","author":"Wijaya","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phymed.2024.155916_bib0038","doi-asserted-by":"crossref","first-page":"13498","DOI":"10.1038\/ncomms13498","article-title":"CUG-binding protein 1 regulates HSC activation and liver fibrogenesis","volume":"7","author":"Wu","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phymed.2024.155916_bib0039","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.766855","article-title":"Novel therapeutic targets in liver fibrosis","volume":"8","author":"Zhang","year":"2021","journal-title":"Front. Mol. Biosci."},{"issue":"5","key":"10.1016\/j.phymed.2024.155916_bib0040","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S2095-4964(14)60039-X","article-title":"Traditional Chinese medicine for treatment of liver diseases: progress, challenges and opportunities","volume":"12","author":"Zhao","year":"2014","journal-title":"J. Integr. Med."},{"key":"10.1016\/j.phymed.2024.155916_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2021.115530","article-title":"Fraxinellone alleviates kidney fibrosis by inhibiting CUG-binding protein 1-mediated fibroblast activation","volume":"420","author":"Zheng","year":"2021","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.phymed.2024.155916_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115794","article-title":"Qijia rougan formula ameliorates ECM deposition in hepatic fibrosis by regulating the JAK1\/STAT6-microRNA-23a feedback loop in macrophage M2 polarization","volume":"168","author":"Zheng","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.phymed.2024.155916_bib0043","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3389\/fphar.2020.00425","article-title":"Deciphering the pharmacological mechanisms of Taohe-Chengqi decoction extract against renal fibrosis through integrating network pharmacology and experimental validation in vitro and in vivo","volume":"11","author":"Zhou","year":"2020","journal-title":"Front. Pharmacol."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711324005749?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711324005749?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T17:21:52Z","timestamp":1724865712000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711324005749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":43,"alternative-id":["S0944711324005749"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2024.155916","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Jiawei Taohe Chengqi Decoction attenuates CCl4 induced hepatic fibrosis by inhibiting HSCs activation via TGF-\u03b21\/CUGBP1 and IFN-\u03b3\/Smad7 pathway","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2024.155916","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"155916"}}